Clinical Trials Directory

Trials / Unknown

UnknownNCT04152044

Obesity and Liver Function in Oesophageal Cancer

Elucidating the Role of Obesity, Liver Function and Pathology With Overall Outcomes in Oesophageal Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
658 (estimated)
Sponsor
St. James's Hospital, Ireland · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

There is an established link between sarcopenia and outcomes in oesophageal cancer. There is scant reports in the literature regarding the influences of different obesity in different compartments.

Detailed description

Oesophageal cancer rates are increasing as a result of obesity in Western society. Thr investigators are evaluating the influence of viscerala dn subcutaneous obesity on overall outcomes of the participants. In addition the investigators are evaluating if there is a correlation with Liver Function Tests and liver histopathology such as steatosis on survival in participants and post operative sequele.

Conditions

Interventions

TypeNameDescription
OTHERObservation of different types of obesity and liver pathology in patients undergoing and oesophagectomyPatinets undergoing surgery

Timeline

Start date
2019-11-01
Primary completion
2020-07-01
Completion
2020-11-01
First posted
2019-11-05
Last updated
2019-11-05

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT04152044. Inclusion in this directory is not an endorsement.

Obesity and Liver Function in Oesophageal Cancer (NCT04152044) · Clinical Trials Directory